vantagebiotrials, Author at Vantage Biotrials

news-homepage-EN août 22, 2023 vantagebiotrials Comments: 0

Vantage BioTrials Is Now Using Smartsheet Clinical Trial Management System

July 18, 2022, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has on-boarded a robust technology solution to manage its growing demand of early/late phase and medical device clinical trials. Accuracy, flexibility, and speed in obtaining real-time data are crucial. During the last couple of years of the Covid-19 pandemic, Vantage BioTrials remained focused in identifying areas of development that will add value to the overall maintenance, tracking a...

news-homepage-EN août 22, 2023 vantagebiotrials Comments: 0

Vantage BioTrials Successfully Manages Real-World Effectiveness of Adalimumab in Patients with Moderate-to-Severe Hidradenitis Suppurativa: the 1-Year SOLACE Study

August 30, 2021, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), is proud to have successfully managed, and completed approximately 12 months in advance, a Phase IV observational, multicentre, postmarketing study in adult patients with a clinical diagnosis of moderate-to-severe Hidradenitis suppurativa (HS). The primary objective of this clinical trial was to measure real-world effectiveness of adalimumab in HS and to secondarily observe clinical <...

news-homepage-EN août 22, 2023 vantagebiotrials Comments: 0

COVID-19 Clinical Trial Managed by Vantage BioTrials Receives Green-Light from FDA to Proceed in the United States

August 27, 2020, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), has partnered with its biotech Sponsor, Laurent Pharmaceuticals, to lead all clinical trial management activities of their lead oral drug candidate LAU-7b in a multicentric Phase 2 placebo-controlled clinical trial (RESOLUTION) in patients with COVID-19. We are pleased to join Laurent Pharmaceuticals in announcing that approval has been received from the Food and Drug Administration (FD...

news-homepage-EN août 22, 2023 vantagebiotrials Comments: 0

Innovative Medicines Canada Interviews President of Vantage BioTrials about the Challenges of Conducting Clinical Trials during COVID-19 Pandemic

MONTREAL, May 20, 2020 –Vantage BioTrials, a member of IMC, is a full-service Contract Research Organization (CRO) based in Canada that provides Phase I-IV clinical trial management services to pharmaceutical, biotechnology and medical device companies. Amid the on-going COVID-19 pandemic, our President, Vatche Bartekian, was interviewed by IMC about the current crisis and provided some insights on how Vantage BioTrials is overcoming some of the challenges caused by COVID-19. Below is the det...

news-pressroom-EN avril 22, 2023 vantagebiotrials Comments: 0

Vantage BioTrials Has Gone Virtual

April 24, 2023, Montréal, Canada – Long before the COVID-19 pandemic, Vantage BioTrials had established the need to virtualize and offer its employees flexibility by offering remote working conditions. As a niche CRO, we believe in making a difference by striving to find better ways to reduce our carbon footprint, be productive and more efficient. By going virtual, we are achieving the following benefits: Reducing Waste and Carbon Footprint: We have digitized all SOPs and Policies and as a r...

White Papers-FR novembre 3, 2022 vantagebiotrials Comments: 0

Perfectly on Time: Successfully Managing Clinical Trial Deliverables

Perfectly on Time: Successfully Managing Clinical Trial Deliverables Publication date: November 2022 / Download PDF Authors: Vatche Bartekian, Johanna Garcia, Sheila Ernest Introduction A key skill for clinical Project Managers (PM) within the life sciences industry is time management. As a PM, you are not only responsible for the project deliverables, but for every person involved as well as every task performed. Yes, it is a team effort however, in the end, the PM is the one responsible for d...

White Papers-FR septembre 3, 2022 vantagebiotrials Comments: 0

Planning a Positive Outcome for Your Clinical Trial

Planning a Positive Outcome for Your Clinical Trial Publication date: September 2022 / Download PDF Author: Vatche Bartekian Co-Authors: Johanna Garcia, Kaiser Lagman, Marina Ohouo, Sheila Ernest Introduction The drug development process presents many complex steps and requires a keen set of skills, knowledge, and resources to arrive successfully at subsequent stages . Within the various phases of drug development, clinical trials, in particular, require robust, coordinated processes and systems...

events-EN août 22, 2022 vantagebiotrials Comments: 0

CRAC Conference | Health Canada Inspectorate Update | June 8, 2023

Vantage BioTrials will be attending the CRAC Dinner Meeting Event on June 8, 2023 where Health Canada will be presenting the latest on the inspections and trends from 2022. For more information about this conference, please click here....

news-pressroom-EN juillet 22, 2022 vantagebiotrials Comments: 0

Vantage BioTrials Is Now Using Smartsheet Clinical Trial Management System

July 18, 2022, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has on-boarded a robust technology solution to manage its growing demand of early/late phase and medical device clinical trials. Accuracy, flexibility, and speed in obtaining real-time data are crucial. During the last couple of years of the Covid-19 pandemic, Vantage BioTrials remained focused in identifying areas of development that will add value to the overall maintenance, tracking a...

news-pressroom-EN août 22, 2021 vantagebiotrials Comments: 0

Vantage BioTrials Successfully Manages Real-World Effectiveness of Adalimumab in Patients with Moderate-to-Severe Hidradenitis Suppurativa: the 1-Year SOLACE Study

August 30, 2021, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), is proud to have successfully managed, and completed approximately 12 months in advance, a Phase IV observational, multicentre, postmarketing study in adult patients with a clinical diagnosis of moderate-to-severe Hidradenitis suppurativa (HS). The primary objective of this clinical trial was to measure real-world effectiveness of adalimumab in HS and to secondarily observe cli...